Nano-X Imaging Business Summary

Nano-X Imaging Ltd. (NNOX) operates a disruptive "Medical Screening as a Service" (MSaaS) business model, shifting the traditional high-capital expenditure medical imaging market toward a usage-based, pay-per-scan, and subscription revenue framework. The company's operations are divided into three primary segments: the Nanox.ARC division, which commercializes its proprietary cold-cathode MEMS-based digital X-ray source; the Radiology Services division, providing teleradiology through its USARAD subsidiary; and the AI Solutions division (Nanox.AI), which offers automated diagnostic software for chronic disease detection. As of early 2026, Nano-X is aggressively scaling its global footprint, recently securing FDA 510(k) clearance for its TAP2D image enhancement capability and expanding distribution across Europe and Latin America. The company competes directly with legacy imaging giants GE Healthcare, Siemens Healthineers, and Philips, as well as specialized medical tech firms like ClearPoint Neuro and NeuroPace, positioning itself as a low-cost, high-accessibility alternative designed to democratize diagnostic imaging in underserved markets. Nano-X was co-founded by serial entrepreneur Ran Poliakine (who served as Chairman until his passing in 2024) and Hitoshi Masuya, leveraging technology developed through a decade-long Israeli-Japanese collaboration. The current leadership team is headed by CEO and Acting Chairman Erez Meltzer, a seasoned executive with a pedigree that includes CEO roles at Netafim, Africa Israel, and Gadot Chemicals, as well as a six-year chairmanship at Hadassah Medical Center. Supporting him are CFO Ran Daniel, a CPA and CFA with over 25 years of financial leadership in public entities, and CTO Dr. Yuval Shani, who oversees the core digital X-ray technology. The company's strategic stability is bolstered by high-profile institutional backing from SK Telecom, which remains a major strategic partner and investor, and BlackRock. The board of directors features notable industry veterans such as Dan Suesskind, the former long-time CFO of Teva Pharmaceuticals, and Michael Jackman, a former senior executive at GE Healthcare and Eastman Kodak.